Showing 2531-2540 of 2812 results for "".
- AestheticsWire Exclusive: Meet Allē, Allergan’s Upgraded Patient Loyalty Programhttps://modernaesthetics.com/news/aestheticswire-exclusive-meet-alle-allergans-upgraded-patient-loyalty-program/2472858/Allergan’s Brilliant Distinctions customer loyalty program is getting a facelift in honor of its 2nd decade. The program is smarter, faster and now goes by Allē. It’s much more than a new name, shares Carrie Strom, Allergan’s Senior Vice President o
- Victoria's Secret Models Shrink While Average US Women's Dress Sizes Increasehttps://modernaesthetics.com/news/victoria-secret-models-shrink-while-average-us-womens-dress-sizes-increase/2472857/While the average American woman's waist circumference and dress size has increased over the past 20 years, Victoria's Secret fashion models have become more slender, with a decrease in bust, waist, hips and dress size, though their waist to hip ratio (WHR) has remained constant, accordin
- BTL Files Patent Infringement Lawsuit Against Allergan and Zimmer Related to Emsculpthttps://modernaesthetics.com/news/btl-files-patent-infringement-lawsuit-against-allergan-and-zimmer-related-to-emsculpt/2472855/BTL Aesthetics' US affiliate has filed a lawsuit against Allergan plc, Ireland and its affiliates, and Zimmer MedizinSysteme GmbH, Germany, and its affiliate, in the US Federal District Court for the District of Delaware. The lawsuit asserts
- Alastin Skincare Receives Third Patenthttps://modernaesthetics.com/news/elastin-skincare-receives-third-patent/2472853/Alastin Skincare, Inc. has received a third US Patent from the United States Patent and Trademark Office. The patent covers Alastin’s innovative science and products. US Patent No. 10,493,011 is entitled, "Peptide Compositions and Methods for Ameliorating Skin Laxity and Bod
- It's A Deal: Baring Private Equity Asia Agrees to Acquire Lumenishttps://modernaesthetics.com/news/its-a-deal-baring-private-equity-asia-agrees-to-acquire-lumenis/2472848/Baring Private Equity Asia’s affiliated private equity funds are acquiring Lumenis. The transaction, which values Lumenis at an enterprise value of more than $1 billion, remains subject to the customary regulatory approval process. It is expected to be completed in early 2020. <
- Save the Date: November 20, 2019 Marks National Botox Dayhttps://modernaesthetics.com/news/save-the-date-november-20th-2019-marks-national-botox-day/2472845/November 20, 2019 will be the first-ever National Botox Cosmetic Day. Why Nov. 20? It is the busiest day on record for booking Botox cosmetic treatments in the US. And to commemorate it, Allergan is offering an exclusive deal for one day only where patients can “buy one, get
- Dr. Roy Geronemus Awarded the Vic Narurkar, MD Innovations in Aesthetic Dermatology Lectureship Awardhttps://modernaesthetics.com/news/dr-roy-geronemus-awarded-the-vic-narurkar-md-innovations-in-aesthetic-dermatology-lectureship-award-1/2472843/Roy Geronemus, MD of Laser & Skin Surgery Center of New York received, The American Society for Dermatologic Surgery inaugural Vic Narurkar, M.D., Innovations in Aesthetic Dermatology Lectureship Award Dr. Geronemus received the award at the 2019 ASDS annual meeting in Chicago. He d
- Does Plastic Surgery Training Have Negative Effects on Reproductive Health?https://modernaesthetics.com/news/does-plastic-surgery-training-have-negative-effects-on-reproductive-health/2472840/Plastic surgery training takes a toll on childbearing and reproductive health, including negative effects on fertility, complications during pregnancy, and breastfeeding practices, reports a study in Plastic and Reconstructive Surgery. The study is the first to focus on reprodu
- FDA Proposes Boxed Warning on Breast Implant Riskshttps://modernaesthetics.com/news/fda-proposes-boxed-warning-on-breast-implant-risks/2472837/The FDA released a statement on its continued efforts to protect women’s health and enhance safety information available to patients considering breast implants. In draft guidance issued on Oct. 24, the FDA proposed labeling
- Dominion Aesthetic and IPS Design New Fat Reduction Devicehttps://modernaesthetics.com/news/dominion-aesthetic-and-ips-design-new-fat-reduction-device/2472835/Intelligent Product Solutions is helping Dominion Aesthetic Technologies, Inc. give their eon FR body contouring device a sleek new look, the companies report. eon FR is a non-contact aesthetic device that is FDA-cleared for abdominal fat reduction. Laser energy is